Aβ-IN-6

Aβ-IN-6 is an orally bioavailable small molecule for Alzheimer's disease research. It exhibits neuroprotective properties by inhibiting Aβ oligomerization, reducing microglial cytokine release, and activating the Nrf2 antioxidant pathway, as demonstrated in both cellular and in vivo oxidative stress models.